204 related articles for article (PubMed ID: 25864879)
1. Study of the Function of G-Rich Aptamers Selected for Lung Adenocarcinoma.
Hu J; Zhao Z; Liu Q; Ye M; Hu B; Wang J; Tan W
Chem Asian J; 2015 Jul; 10(7):1519-25. PubMed ID: 25864879
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
3. Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.
Ogloblina AM; Iaccarino N; Capasso D; Di Gaetano S; Garzarella EU; Dolinnaya NG; Yakubovskaya MG; Pagano B; Amato J; Randazzo A
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096752
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.
Reyes-Reyes EM; Šalipur FR; Shams M; Forsthoefel MK; Bates PJ
Mol Oncol; 2015 Aug; 9(7):1392-405. PubMed ID: 25911416
[TBL] [Abstract][Full Text] [Related]
5. G-quadruplex structure of an anti-proliferative DNA sequence.
Do NQ; Chung WJ; Truong THA; Heddi B; Phan AT
Nucleic Acids Res; 2017 Jul; 45(12):7487-7493. PubMed ID: 28549181
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.
Holmboe S; Hansen PL; Thisgaard H; Block I; Müller C; Langkjær N; Høilund-Carlsen PF; Olsen BB; Mollenhauer J
PLoS One; 2017; 12(5):e0178286. PubMed ID: 28542563
[TBL] [Abstract][Full Text] [Related]
7. Cancer-selective antiproliferative activity is a general property of some G-rich oligodeoxynucleotides.
Choi EW; Nayak LV; Bates PJ
Nucleic Acids Res; 2010 Mar; 38(5):1623-35. PubMed ID: 20008101
[TBL] [Abstract][Full Text] [Related]
8. Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
Shieh YA; Yang SJ; Wei MF; Shieh MJ
ACS Nano; 2010 Mar; 4(3):1433-42. PubMed ID: 20166743
[TBL] [Abstract][Full Text] [Related]
9. Bioactivity of 2'-deoxyinosine-incorporated aptamer AS1411.
Fan X; Sun L; Wu Y; Zhang L; Yang Z
Sci Rep; 2016 May; 6():25799. PubMed ID: 27194215
[TBL] [Abstract][Full Text] [Related]
10. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
[TBL] [Abstract][Full Text] [Related]
11. Backbone modified TBA analogues endowed with antiproliferative activity.
Esposito V; Russo A; Amato T; Varra M; Vellecco V; Bucci M; Russo G; Virgilio A; Galeone A
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1213-1221. PubMed ID: 27663232
[TBL] [Abstract][Full Text] [Related]
12. Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR.
Chang CC; Hsieh TL; Tiong TY; Hsiao CH; Ji AT; Hsu WT; Lee OK; Ho JH
Biomaterials; 2015 Aug; 60():141-50. PubMed ID: 26000960
[TBL] [Abstract][Full Text] [Related]
13. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
15. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell proliferation by an anti-EGFR aptamer.
Li N; Nguyen HH; Byrom M; Ellington AD
PLoS One; 2011; 6(6):e20299. PubMed ID: 21687663
[TBL] [Abstract][Full Text] [Related]
17. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer.
Bates PJ; Laber DA; Miller DM; Thomas SD; Trent JO
Exp Mol Pathol; 2009 Jun; 86(3):151-64. PubMed ID: 19454272
[TBL] [Abstract][Full Text] [Related]
18. Exploring New Potential Anticancer Activities of the G-Quadruplexes Formed by [(GTG
Virgilio A; Benigno D; Pecoraro A; Russo A; Russo G; Esposito V; Galeone A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208896
[TBL] [Abstract][Full Text] [Related]
19. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell.
Lohlamoh W; Soontornworajit B; Rotkrua P
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and the interaction of 2-(1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthrolines with telomeric DNA as lung cancer inhibitors.
Liu J; Chen M; Wang Y; Zhao X; Wang S; Wu Y; Zhang W
Eur J Med Chem; 2017 Jun; 133():36-49. PubMed ID: 28376371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
